LONDON — ATAI Life Science, a Peter Thiel-backed start-up, has taken a majority stake in Recognify, a company that is developing drugs to help treat schizophrenia.

Several Canadian cannabis company CEOs were among the highest paid corporate executives in the nation in 2019, according to a Centre for Policy Alternatives’ analysis titled “The Golden Cushion: CEO compensation in Canada.”

BetterLife Pharma Inc tapped the experience of psychedelic pioneer Hattie Wells to join its new psychedelic research advisory board.

In his State of the State address on Wednesday, Connecticut Gov. Ned Lamont (D) said he planned to work to legalize cannabis in the coming session.

Oakland, California–(Newsfile Corp. – January 11, 2021) – The Magic Mushroom Company (OTCP Pink: MINE) specializing in growing, research, production and distribution of psilocybin mushrooms, announced today that Paul Hoonjan has been appointed as its new President.

Tony White called his therapy session powered by magic mushrooms “a good trip.”

KCSA Communications hosts an investment conference featuring Rick Doblin (MAPS) as a keynote speaker.

ATAI Life Sciences and MindMed Inc have the deepest psychedelics operations in this sector. Which is the better opportunity?

MindCure signs LOI to make a strategic investment in ATMA, a psychedelics-assisted therapy center in Calgary, Alberta.

Clinical studies continue to support the use of psilocybin for mental health. For example, a study from JAMA Psychiatry found that psilocybin “worked better than the usual antidepressant medications,” as noted by NPR.